<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">IJCM</journal-id><journal-title-group><journal-title>International Journal of Clinical Medicine</journal-title></journal-title-group><issn pub-type="epub">2158-284X</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ijcm.2015.68072</article-id><article-id pub-id-type="publisher-id">IJCM-58617</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Link between Friesinger Index and Lipid Profile in Patients Undergoing Diagnostic Coronary Angiography
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>eepesh</surname><given-names>Agarwal</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ramanand</surname><given-names>P. Sinha</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ram</surname><given-names>Mohan Jaiswal</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Nikhil</surname><given-names>Pursnani</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Nirlep</surname><given-names>Gajiwala</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ashok</surname><given-names>Thakkar</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Mahatma Gandhi Cardiac and Critical Care Center, Jaipur, India</addr-line></aff><aff id="aff2"><addr-line>Sahajanand Medical Technologies Pvt. Ltd., Surat, India</addr-line></aff><pub-date pub-type="epub"><day>06</day><month>08</month><year>2015</year></pub-date><volume>06</volume><issue>08</issue><fpage>538</fpage><lpage>546</lpage><history><date date-type="received"><day>13</day>	<month>July</month>	<year>2015</year></date><date date-type="rev-recd"><day>accepted</day>	<month>3</month>	<year>August</year>	</date><date date-type="accepted"><day>6</day>	<month>August</month>	<year>2015</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Background: A strong association between abnormal lipid variables and development of atherosclerosis is widely established. However, few data exist on the association between lipid levels and the extent or severity of coronary lesions in patients with coronary artery disease. Objective: We aimed to determine the link between lipid levels and the extent or severity of coronary lesions in patients with suspected coronary artery disease using Friesinger index (FR). Methodology: In this prospective and singe-center study, consecutive patients who underwent coronary angiography for diagnostic purposes were analyzed. Each participant was evaluated for lipid levels i.e. total cholesterol, triglycerides, high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol, very-low-density lipoprotein (VLDL) cholesterol, non-HDL cholesterol, triglycerides/ HDL cholesterol, and triglycerides/non-HDL cholesterol. The extent of coronary disease was evaluated using FR index. Results: A total of 566 patients (mean age: 56.17 &#177; 9.99 years) were included in the study. The mean FR index was 5.40 &#177; 3.78. A significantly positive correlation was observed between FR index and total cholesterol (P = 0.002), triglycerides (P &lt; 0.001), VLDL cholesterol (P &lt; 0.001), non-HDL cholesterol (P = 0.006), triglycerides/HDL cholesterol ratio (P = 0.008), and triglycerides/non-HDL cholesterol ratio (P = 0.002). On the contrary, an inverse correlation was observed between FR index and HDL cholesterol (P &lt; 0.001). Age or gender played no role in governing the FR index severity, while body-mass index, hypertension, diabetes, and smoking showed significant association with FR index (P &lt; 0.001 for all). Conclusion: The present study demonstrates a significant link between the extent of coronary artery disease and levels of certain lipid variables.
 
</p></abstract><kwd-group><kwd>Cholesterol</kwd><kwd> Coronary Angiography</kwd><kwd> Coronary Artery Disease</kwd><kwd> Friesinger Index</kwd><kwd> Lipid Profile</kwd><kwd> Triglyceride</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Lipid abnormality is a well-established risk factor for the development of coronary artery disease [<xref ref-type="bibr" rid="scirp.58617-ref1">1</xref>] . Several clinical and epidemiological studies have indicated a strong association between dyslipidemia and atherosclerosis [<xref ref-type="bibr" rid="scirp.58617-ref2">2</xref>] - [<xref ref-type="bibr" rid="scirp.58617-ref7">7</xref>] . Nevertheless, data on the association between lipid levels and extent or severity of coronary lesions in patients with coronary artery disease are limited [<xref ref-type="bibr" rid="scirp.58617-ref8">8</xref>] . Friesinger (FR) index [<xref ref-type="bibr" rid="scirp.58617-ref9">9</xref>] is an important tool to assess the extent and severity of coronary artery lesions. A significant association between the FR index and lipid levels has been observed in the past years [<xref ref-type="bibr" rid="scirp.58617-ref8">8</xref>] . However, such investigations are very scarce in literature. In this regard, we conducted a study to determine the correlation between lipid variables and the extent or severity of coronary lesions in patients with suspected coronary artery disease.</p></sec><sec id="s2"><title>2. Methodology</title><sec id="s2_1"><title>2.1. Study Design and Patient Population</title><p>In this prospective, singe-center study, consecutive patients who underwent coronary angiography for diagnostic purposes at our center between February 2013 and March 2014 were enrolled. Patients with congenital heart disease, coronary artery anomaly, cancer, obstructive pulmonary illness, or renal insufficiency and those already on hypolipidemic drugs were excluded from the study. A signed form indicating informed consent was obtained from each participating patient. The protocol of the study was approved by the Ethics Committee of our institution and the study was conducted in accordance with the ethical standards of Good Clinical Practice and the Helsinki Declaration.</p></sec><sec id="s2_2"><title>2.2. Data Collection</title><p>All patients were asked to report their age and gender. Body-mass index (BMI) was estimated based on the height and weight measurements. Patients were defined as having hypertension if they displayed a systolic blood pressure ≥ 140 mmHg, diastolic blood pressure ≥ 90 mmHg, or self-report of physician diagnosis of hypertension and/or current use of antihypertensive medications. Diabetes mellitus was considered present if the patient presented with fasting glucose levels &gt; 126 mg/dL, glycated hemoglobin (HbA1c) levels &gt; 6.5%, or self-report of physician diagnosis of diabetes and/or use of antidiabetic medications. Patients were categorized as smokers if they reported smoking within last one year.</p><p>Each participating patient was evaluated for total cholesterol, triglycerides, high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol, very-low-density lipoprotein (VLDL) cholesterol, and non-HDL cholesterol levels using standard techniques. In addition, lipid ratios of triglycerides to HDL cholesterol and triglycerides to non-HDL cholesterol were calculated. Patients with abnormal lipid levels were identified by cutoff points of: &gt;200 mg/dL for total cholesterol, &gt;150 mg/dL for triglycerides, &gt;130 mg/dL for LDL cholesterol, ≤40 mg/dL for HDL cholesterol, &gt;4 for triglycerides/HDL cholesterol ratio, and &gt;0.9 for triglycerides/non-HDL cholesterol ratio.</p><p>All patients underwent coronary angiography through transfemoral/transradial route using standard percutaneous techniques in the typical orthogonal projections. The FR index was used to assess the extent of coronary disease. The scores in this index range from 0 to 15. Each of the three main coronary arteries was scored separately from zero to five. The scores were: 0 for no arteriographic abnormalities, 1 for trivial luminal narrowing of &lt;29%, 2 for localized luminal narrowing of 30% - 68%, 3 for multiple luminal narrowings of 30% - 68%, 4 for luminal narrowing of 69% - 100% without 100% occlusion of proximal segments; and 5 for total obstruction of a proximal segment. [<xref ref-type="bibr" rid="scirp.58617-ref9">9</xref>] Based on these, patients were classified in to four groups: patients with 0 FR index score, patients with 1 - 4 FR index score, patients with 5 - 10 FR index score, and patients with 11 - 15 FR index score.</p></sec><sec id="s2_3"><title>2.3. Analysis of Study Outcomes</title><p>Based on the collected data, we evaluated the differences in mean lipid levels (e.g. total cholesterol, triglycerides, HDL cholesterol, LDL cholesterol, VLDL cholesterol, non-HDL cholesterol, triglycerides/HDL cholesterol, and triglycerides/non-HDL cholesterol) across the groups of patients classified according to their FR index scores. We also determined the correlation between FR index and lipid levels. Subsequently, we assessed the association between severity of FR index and frequencies of patients classified according to the cut-off levels for each lipid variable as well as the association between FR index and demographic variables such as age, gender, BMI, hypertension, diabetes, and smoking.</p></sec><sec id="s2_4"><title>2.4. Statistical Analysis</title><p>The collected data were analyzed using the Statistical Package for Social Sciences (SPSS for Windows version 20.0; Chicago, IL, USA). Continuous variables were described by mean and standard deviation. Categorical variables were presented as frequency and percentage. Non-parametric ANOVA (Kruskal-Wallis) test was used to assess the significant differences in mean lipid levels across FR index groups (e.g. difference in mean total cholesterol levels across FR index groups). Non-parametric spearman’s rho correlation test was used to assess the correlation between two continuous variables (e.g. triglycerides and FR index). Non-parametric Pearson Chi-square test was used to assess the association between categorical variables (e.g. gender and FR index groups). In addition, a binary logistic regression analysis was conducted to predict the extent and severity of cornary artery lesions, in terms of FR index, using lipid variables and demographic characteristics as predictors. The P value &lt; 0.05 was considered to indicate statistical significance.</p></sec></sec><sec id="s3"><title>3. Results</title><sec id="s3_1"><title>3.1. Baseline Demographics</title><p>A total of 566 patients were included in the study. The mean age of study participants was 56.17 &#177; 9.99 years. Of them, 435 (76.9%) were males, 214 (37.8%) had diabetes, 370 (63.4%) had hypertension, and 359 (63.4%) were current smokers. Mean total cholesterol was 182.72 &#177; 52.47 mg/dL, triglyceride was 152.57 &#177; 78.21 mg/dL, HDL cholesterol was 35.37 &#177; 10.25 mg/dL, LDL cholesterol was 116.00 &#177; 45.11 mg/dL, TG/HDL cholesterol ratio was 4.68 &#177; 4.66, and TG/non-HDL cholesterol ratio was 1.09 &#177; 0.60. The mean FR index was 5.40 &#177; 3.78. <xref ref-type="table" rid="table1">Table 1</xref> describes the demographics of patient sample, as well as their distribution according to the FR index.</p></sec><sec id="s3_2"><title>3.2. Lipid Levels across FR Index Groups</title><p>The mean lipid levels across patients classified according to their FR index have been depicted in <xref ref-type="fig" rid="fig1">Figure 1</xref>. Corresponding mean lipid ratios of triglycerides/HDL cholesterol and triglycerides/non-HDL cholesterol across FR index groups are depicted in <xref ref-type="fig" rid="fig2">Figure 2</xref>. Analysis of various lipid variables indicated that there were significant differences between total cholesterol, triglycerides, HDL cholesterol, VLDL cholesterol, and triglycerides/non-HDL cholesterol across the groups of patients according to their FR index (<xref ref-type="table" rid="table2">Table 2</xref>). In addition, a significantly positive correlation was observed between FR index and total cholesterol, triglycerides, VLDL cholesterol, non-HDL cholesterol, triglycerides/HDL cholesterol ratio, and triglycerides/non-HDL cholesterol ratio. On the contrary, an inverse correlation was observed between FR index and HDL cholesterol levels (<xref ref-type="table" rid="table3">Table 3</xref>).</p></sec><sec id="s3_3"><title>3.3. Frequency of Patients with Abnormal Lipid Levels across FR Index Groups</title><p>Analysis of the lipid profile showed that 189 (33.4%) patients had hypercholesterolemia, 194 (34.3%) had high LDL-cholesterolemia, 437 (77.21%) had low HDL-cholesterolemia, 232 (40.1%) had hypertriglyceridemia, 178 (31.5%) had elevated triglycerides/HDL cholesterol ratio, and 317 (56.0%) had elevated triglycerides/non-HDL cholesterol ratio (<xref ref-type="table" rid="table4">Table 4</xref>). A further analysis of frequency of patients classified according to the cut-off lipid levels revealed that variables like HDL cholesterol levels, triglycerides levels, and triglycerides/non-HDL cholesterol ratio had a significant association with severity of FR index (<xref ref-type="table" rid="table4">Table 4</xref>).</p></sec><sec id="s3_4"><title>3.4. Association between FR Index and Demographic Variables</title><p>The association between FR index and demographic variables such as age, gender, BMI, hypertension, diabetes,</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Demographic details of patients included in the study<sup>a</sup></title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Variable</th><th align="center" valign="middle" >566 patients</th></tr></thead><tr><td align="center" valign="middle" >Age, years</td><td align="center" valign="middle" >56.17 &#177; 9.99</td></tr><tr><td align="center" valign="middle" >Males, n (%)</td><td align="center" valign="middle" >435 (76.9)</td></tr><tr><td align="center" valign="middle" >BMI, kg/m<sup>2</sup></td><td align="center" valign="middle" >22.21&#177;2.52</td></tr><tr><td align="center" valign="middle" >Diabetes mellitus, n (%)</td><td align="center" valign="middle" >214 (37.8)</td></tr><tr><td align="center" valign="middle" >Hypertension, n (%)</td><td align="center" valign="middle" >370 (65.4)</td></tr><tr><td align="center" valign="middle" >Smoking, n (%)</td><td align="center" valign="middle" >359 (63.4)</td></tr><tr><td align="center" valign="middle" >Total cholesterol, mg/dL</td><td align="center" valign="middle" >182.72 &#177; 52.47</td></tr><tr><td align="center" valign="middle" >Triglycerides, mg/dL</td><td align="center" valign="middle" >152.57 &#177; 78.21</td></tr><tr><td align="center" valign="middle" >HDL cholesterol, mg/dL</td><td align="center" valign="middle" >35.37 &#177; 10.25</td></tr><tr><td align="center" valign="middle" >LDL cholesterol, mg/dL</td><td align="center" valign="middle" >116.00 &#177; 45.11</td></tr><tr><td align="center" valign="middle" >VLDL cholesterol, mg/dL</td><td align="center" valign="middle" >30.44 &#177; 16.72</td></tr><tr><td align="center" valign="middle" >Non-HDL cholesterol, mg/dL</td><td align="center" valign="middle" >147.35 &#177; 49.02</td></tr><tr><td align="center" valign="middle" >TG/HDL cholesterol</td><td align="center" valign="middle" >4.68 &#177; 4.66</td></tr><tr><td align="center" valign="middle" >TG/non-HDL cholesterol</td><td align="center" valign="middle" >1.09 &#177; 0.60</td></tr><tr><td align="center" valign="middle" >Friesinger index</td><td align="center" valign="middle" >5.40 &#177; 3.78</td></tr><tr><td align="center" valign="middle" >0, n (%)</td><td align="center" valign="middle" >96 (17.0)</td></tr><tr><td align="center" valign="middle" >1 - 4, n (%)</td><td align="center" valign="middle" >150 (26.5)</td></tr><tr><td align="center" valign="middle" >5 - 10, n (%)</td><td align="center" valign="middle" >259 (45.7)</td></tr><tr><td align="center" valign="middle" >11 - 15, n (%)</td><td align="center" valign="middle" >61 (10.8)</td></tr></tbody></table></table-wrap><p><sup>a</sup>Continuous variables are described by mean and standard deviation; categorical variables are presented as frequency and percentage.</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Analysis of lipid levels in patients distributed according to FR index classes</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Variable</th><th align="center" valign="middle"  colspan="4"  >FR index<sup>a</sup></th><th align="center" valign="middle"  rowspan="2"  >P value for group difference<sup>b</sup></th></tr></thead><tr><td align="center" valign="middle" >0 (n = 96)</td><td align="center" valign="middle" >1 - 4 (n = 150)</td><td align="center" valign="middle" >5 - 10 (n = 259)</td><td align="center" valign="middle" >11 - 15 (n = 61)</td></tr><tr><td align="center" valign="middle" >Total cholesterol, mg/dL</td><td align="center" valign="middle" >169.61 &#177; 51.39</td><td align="center" valign="middle" >180.36 &#177; 47.50</td><td align="center" valign="middle" >185.95 &#177; 51.97</td><td align="center" valign="middle" >195.54 &#177; 63.80</td><td align="center" valign="middle" >0.022</td></tr><tr><td align="center" valign="middle" >Triglycerides, mg/dL</td><td align="center" valign="middle" >136.51 &#177; 79.48</td><td align="center" valign="middle" >137.53 &#177; 59.28</td><td align="center" valign="middle" >157.43 &#177; 72.72</td><td align="center" valign="middle" >194.36 &#177; 115.60</td><td align="center" valign="middle" >&lt;0.001</td></tr><tr><td align="center" valign="middle" >HDL cholesterol, mg/dL</td><td align="center" valign="middle" >37.18 &#177; 8.46</td><td align="center" valign="middle" >36.28 &#177; 8.71</td><td align="center" valign="middle" >34.45 &#177; 13.15</td><td align="center" valign="middle" >33.18 &#177; 9.61</td><td align="center" valign="middle" >&lt;0.001</td></tr><tr><td align="center" valign="middle" >LDL cholesterol, mg/dL</td><td align="center" valign="middle" >108.03 &#177; 40.45</td><td align="center" valign="middle" >116.48 &#177; 42.56</td><td align="center" valign="middle" >117.34 &#177; 45.54</td><td align="center" valign="middle" >121.70 &#177; 54.94</td><td align="center" valign="middle" >0.301</td></tr><tr><td align="center" valign="middle" >VLDL cholesterol, mg/dL</td><td align="center" valign="middle" >27.91 &#177; 16.67</td><td align="center" valign="middle" >27.77 &#177; 14.13</td><td align="center" valign="middle" >31.55 &#177; 17.24</td><td align="center" valign="middle" >36.28 &#177; 18.89</td><td align="center" valign="middle" >&lt;0.001</td></tr><tr><td align="center" valign="middle" >Non-HDL cholesterol, mg/dL</td><td align="center" valign="middle" >136.44 &#177; 47.71</td><td align="center" valign="middle" >145.91 &#177; 44.36</td><td align="center" valign="middle" >149.67 &#177; 48.59</td><td align="center" valign="middle" >158.36 &#177; 60.69</td><td align="center" valign="middle" >0.061</td></tr><tr><td align="center" valign="middle" >Triglycerides/HDL cholesterol</td><td align="center" valign="middle" >4.20 &#177; 2.13</td><td align="center" valign="middle" >4.47 &#177; 3.00</td><td align="center" valign="middle" >4.69 &#177; 4.85</td><td align="center" valign="middle" >5.95 &#177; 8.47</td><td align="center" valign="middle" >0.140</td></tr><tr><td align="center" valign="middle" >Triglycerides/non-HDL cholesterol</td><td align="center" valign="middle" >1.05 &#177; 0.59</td><td align="center" valign="middle" >0.99 &#177; 0.44</td><td align="center" valign="middle" >1.12 &#177; 0.60</td><td align="center" valign="middle" >1.28 &#177; 0.88</td><td align="center" valign="middle" >0.010</td></tr></tbody></table></table-wrap><p><sup>a</sup>Data are presented as mean &#177; standard deviation; <sup>b</sup>Kruskal-Wallis Test.</p><p>and smoking is described in <xref ref-type="table" rid="table5">Table 5</xref>. We found that age or gender played no role in governing the FR index severity. However, characteristics such as BMI, hypertension, diabetes, and smoking showed significant association with FR index.</p><fig id="fig1"  position="float"><label><xref ref-type="fig" rid="fig1">Figure 1</xref></label><caption><title> Mean lipid levels across FR index groups</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/3-2101167x5.png"/></fig><fig id="fig2"  position="float"><label><xref ref-type="fig" rid="fig2">Figure 2</xref></label><caption><title> Mean lipid ratios across FR index groups</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/3-2101167x6.png"/></fig></sec><sec id="s3_5"><title>3.5. Logistic Regression Analysis</title><p><xref ref-type="table" rid="table6">Table 6</xref> represents the major findings of the binary logistic regression analysis conducted in the study. Among the variables analyzed, presence of diabetes displayed the strongest correlation with FR index (odds ratio: 7.710, P &lt; 0.001). Other variables showing significant correlation with FR index were BMI (odds ratio: 1.106, P =</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Analysis of correlation between FR index and lipid variables</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Variable</th><th align="center" valign="middle"  colspan="2"  >Correlation with FR index<sup>a</sup></th></tr></thead><tr><td align="center" valign="middle" >Correlation coefficient</td><td align="center" valign="middle" >P value for correlation</td></tr><tr><td align="center" valign="middle" >Total cholesterol, mg/dL</td><td align="center" valign="middle" >0.131</td><td align="center" valign="middle" >0.002</td></tr><tr><td align="center" valign="middle" >Triglycerides, mg/dL</td><td align="center" valign="middle" >0.217</td><td align="center" valign="middle" >&lt;0.001</td></tr><tr><td align="center" valign="middle" >HDL cholesterol, mg/dL</td><td align="center" valign="middle" >−0.185</td><td align="center" valign="middle" >&lt;0.001</td></tr><tr><td align="center" valign="middle" >LDL cholesterol, mg/dL</td><td align="center" valign="middle" >0.060</td><td align="center" valign="middle" >0.153</td></tr><tr><td align="center" valign="middle" >VLDL cholesterol, mg/dL</td><td align="center" valign="middle" >0.191</td><td align="center" valign="middle" >&lt;0.001</td></tr><tr><td align="center" valign="middle" >Non-HDL cholesterol, mg/dL</td><td align="center" valign="middle" >0.116</td><td align="center" valign="middle" >0.006</td></tr><tr><td align="center" valign="middle" >Triglycerides/HDL cholesterol</td><td align="center" valign="middle" >0.112</td><td align="center" valign="middle" >0.008</td></tr><tr><td align="center" valign="middle" >Triglycerides/non-HDL cholesterol</td><td align="center" valign="middle" >0.130</td><td align="center" valign="middle" >0.002</td></tr></tbody></table></table-wrap><p><sup>a</sup>Spearman’s rho correlation test.</p><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> Analysis of frequency of patients according to the cut-off lipid levels across FR index groups</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Variables</th><th align="center" valign="middle"  rowspan="2"  >Cut-off subgroups</th><th align="center" valign="middle"  colspan="4"  >FR index<sup>a</sup></th><th align="center" valign="middle"  rowspan="2"  >P value for association<sup>b</sup></th></tr></thead><tr><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1 - 4</td><td align="center" valign="middle" >5 - 10</td><td align="center" valign="middle" >11 - 15</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Total cholesterol</td><td align="center" valign="middle" >≤200 mg/dL (n = 377)</td><td align="center" valign="middle" >73 (19.4)</td><td align="center" valign="middle" >100 (26.5)</td><td align="center" valign="middle" >165 (43.8)</td><td align="center" valign="middle" >39 (10.3)</td><td align="center" valign="middle"  rowspan="2"  >0.159</td></tr><tr><td align="center" valign="middle" >&gt;200 mg/dL (n = 189)</td><td align="center" valign="middle" >23 (12.2)</td><td align="center" valign="middle" >50 (26.5)</td><td align="center" valign="middle" >95 (49.7)</td><td align="center" valign="middle" >22 (11.6)</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >HDL cholesterol</td><td align="center" valign="middle" >&gt;40 mg/dL (n = 129)</td><td align="center" valign="middle" >16 (12.4)</td><td align="center" valign="middle" >24 (18.6)</td><td align="center" valign="middle" >67 (51.9)</td><td align="center" valign="middle" >22 (17.1)</td><td align="center" valign="middle"  rowspan="2"  >0.004</td></tr><tr><td align="center" valign="middle" >≤40 mg/dL (n = 437)</td><td align="center" valign="middle" >80 (18.3)</td><td align="center" valign="middle" >126 (28.8)</td><td align="center" valign="middle" >192 (43.9)</td><td align="center" valign="middle" >39 (8.9)</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >LDL cholesterol</td><td align="center" valign="middle" >≤130 mg/dL (n = 371)</td><td align="center" valign="middle" >69 (18.6)</td><td align="center" valign="middle" >97 (26.1)</td><td align="center" valign="middle" >165 (44.5)</td><td align="center" valign="middle" >40 (10.8)</td><td align="center" valign="middle"  rowspan="2"  >0.563</td></tr><tr><td align="center" valign="middle" >&gt;130 mg/dL (n = 194)</td><td align="center" valign="middle" >27 (13.9)</td><td align="center" valign="middle" >53 (27.3)</td><td align="center" valign="middle" >93 (47.9)</td><td align="center" valign="middle" >21 (10.8)</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Triglycerides</td><td align="center" valign="middle" >≤150 mg/dL (n = 334)</td><td align="center" valign="middle" >66 (19.8)</td><td align="center" valign="middle" >98 (29.3)</td><td align="center" valign="middle" >143 (42.8)</td><td align="center" valign="middle" >27 (8.1)</td><td align="center" valign="middle"  rowspan="2"  >0.004</td></tr><tr><td align="center" valign="middle" >&gt;150 mg/dL (n = 232)</td><td align="center" valign="middle" >30 (12.9)</td><td align="center" valign="middle" >52 (22.2)</td><td align="center" valign="middle" >116 (50.0)</td><td align="center" valign="middle" >34 (14.7)</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Triglycerides/HDL cholesterol</td><td align="center" valign="middle" >≤4 (n = 388)</td><td align="center" valign="middle" >68 (17.5)</td><td align="center" valign="middle" >107 (27.6)</td><td align="center" valign="middle" >175 (45.1)</td><td align="center" valign="middle" >38 (9.8)</td><td align="center" valign="middle"  rowspan="2"  >0.574</td></tr><tr><td align="center" valign="middle" >&gt;4 (n = 178)</td><td align="center" valign="middle" >28 (15.7)</td><td align="center" valign="middle" >43 (24.2)</td><td align="center" valign="middle" >84 (47.2)</td><td align="center" valign="middle" >23 (12.9)</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Triglycerides/non-HDL cholesterol</td><td align="center" valign="middle" >≤0.9 (n = 249)</td><td align="center" valign="middle" >48 (19.3)</td><td align="center" valign="middle" >76 (30.5)</td><td align="center" valign="middle" >108 (43.3)</td><td align="center" valign="middle" >17 (6.8)</td><td align="center" valign="middle"  rowspan="2"  >0.011</td></tr><tr><td align="center" valign="middle" >&gt;0.9 (n = 317)</td><td align="center" valign="middle" >48 (15.1)</td><td align="center" valign="middle" >74 (23.3)</td><td align="center" valign="middle" >151 (47.6)</td><td align="center" valign="middle" >44 (13.9)</td></tr></tbody></table></table-wrap><p><sup>a</sup>Data are presented as number of patients (percentage of patients); <sup>b</sup>Pearson Chi-square test for association.</p><p>0.032), status of hypertension (odds ratio: 3.713, P &lt; 0.001), and smoking (odds ratio: 5.784, P &lt; 0.001). On the other hand, age and gender showed a weak insignificant correlation with FR index. Of note, the relationship between FR index and all lipid variables was found to be statistically insignificant.</p></sec></sec><sec id="s4"><title>4. Discussion</title><p>In this study, we demonstrate a significant association between the extent of coronary artery disease and certain lipid variables in patients with suspected coronary artery disease. Identification of this strong association between lipid levels and the extent of coronary artery disease may help in deciding the potential management strategy for patients with acute coronary syndromes.</p><p>High levels of LDL cholesterol are directly correlated with coronary artery disease [<xref ref-type="bibr" rid="scirp.58617-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.58617-ref11">11</xref>] , while low levels of HDL cholesterol have been considered as one of the strongest independent risk factors for the development of coronary artery disease [<xref ref-type="bibr" rid="scirp.58617-ref12">12</xref>] [<xref ref-type="bibr" rid="scirp.58617-ref13">13</xref>] . It has also been established that mild increases in triglyceride levels lead to</p><table-wrap id="table5" ><label><xref ref-type="table" rid="table5">Table 5</xref></label><caption><title> Analysis of association between FR index and demographic variables</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Variable</th><th align="center" valign="middle"  colspan="5"  >FR index<sup>a</sup></th><th align="center" valign="middle"  rowspan="2"  >P value for association<sup>b</sup></th></tr></thead><tr><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1 - 4</td><td align="center" valign="middle" >5 - 10</td><td align="center" valign="middle"  colspan="2"  >11 - 15</td></tr><tr><td align="center" valign="middle"  colspan="7"  >Age</td></tr><tr><td align="center" valign="middle" >≤50 years (n = 152)</td><td align="center" valign="middle" >25 (16.4)</td><td align="center" valign="middle" >44 (28.9)</td><td align="center" valign="middle" >66 (43.4)</td><td align="center" valign="middle"  colspan="2"  >17 (11.2)</td><td align="center" valign="middle"  rowspan="3"  >0.853</td></tr><tr><td align="center" valign="middle" >51 - 60 years (n = 257)</td><td align="center" valign="middle" >49 (19.1)</td><td align="center" valign="middle" >63 (24.5)</td><td align="center" valign="middle" >118 (45.9)</td><td align="center" valign="middle"  colspan="2"  >27 (10.5)</td></tr><tr><td align="center" valign="middle" >&gt;60 years (n = 157)</td><td align="center" valign="middle" >22 (14.0)</td><td align="center" valign="middle" >43 (27.4)</td><td align="center" valign="middle" >75 (47.8)</td><td align="center" valign="middle"  colspan="2"  >17 (10.8)</td></tr><tr><td align="center" valign="middle"  colspan="7"  >Gender</td></tr><tr><td align="center" valign="middle" >Female (n = 131)</td><td align="center" valign="middle" >30 (22.9)</td><td align="center" valign="middle" >27 (20.6)</td><td align="center" valign="middle" >61 (46.6)</td><td align="center" valign="middle"  colspan="2"  >13 (9.9)</td><td align="center" valign="middle"  rowspan="2"  >0.116</td></tr><tr><td align="center" valign="middle" >Male (n = 435)</td><td align="center" valign="middle" >66 (15.2)</td><td align="center" valign="middle" >123 (28.3)</td><td align="center" valign="middle" >198 (45.5)</td><td align="center" valign="middle"  colspan="2"  >48 (11.0)</td></tr><tr><td align="center" valign="middle"  colspan="7"  >BMI</td></tr><tr><td align="center" valign="middle" >≤25 kg/m<sup>2</sup> (n = 464)</td><td align="center" valign="middle" >84 (18.1)</td><td align="center" valign="middle" >134 (28.9)</td><td align="center" valign="middle"  colspan="2"  >208 (44.8)</td><td align="center" valign="middle" >38 (8.2)</td><td align="center" valign="middle"  rowspan="2"  >&lt;0.001</td></tr><tr><td align="center" valign="middle" >&gt;25 kg/m<sup>2</sup> (n = 102)</td><td align="center" valign="middle" >12 (11.8)</td><td align="center" valign="middle" >16 (15.7)</td><td align="center" valign="middle"  colspan="2"  >51 (50.0)</td><td align="center" valign="middle" >23 (22.5)</td></tr><tr><td align="center" valign="middle"  colspan="7"  >Hypertension</td></tr><tr><td align="center" valign="middle" >Hypertensive (n = 370)</td><td align="center" valign="middle" >31 (8.4)</td><td align="center" valign="middle" >79 (21.3)</td><td align="center" valign="middle"  colspan="2"  >205 (55.4)</td><td align="center" valign="middle" >55 (14.9)</td><td align="center" valign="middle"  rowspan="2"  >&lt;0.001</td></tr><tr><td align="center" valign="middle" >Nonhypertensive (n = 196)</td><td align="center" valign="middle" >65 (33.2)</td><td align="center" valign="middle" >71 (36.2)</td><td align="center" valign="middle"  colspan="2"  >54 (27.5)</td><td align="center" valign="middle" >6 (3.1)</td></tr><tr><td align="center" valign="middle"  colspan="7"  >Diabetes</td></tr><tr><td align="center" valign="middle" >Diabetic (n = 214)</td><td align="center" valign="middle" >15 (7.0)</td><td align="center" valign="middle" >16 (7.5)</td><td align="center" valign="middle"  colspan="2"  >126 (58.9)</td><td align="center" valign="middle" >57 (26.6)</td><td align="center" valign="middle"  rowspan="2"  >&lt;0.001</td></tr><tr><td align="center" valign="middle" >Nondiabetic (n = 352)</td><td align="center" valign="middle" >81 (23.0)</td><td align="center" valign="middle" >134 (38.1)</td><td align="center" valign="middle"  colspan="2"  >133 (37.8)</td><td align="center" valign="middle" >4 (1.1)</td></tr><tr><td align="center" valign="middle"  colspan="7"  >Smoking</td></tr><tr><td align="center" valign="middle" >Smoker (n = 359)</td><td align="center" valign="middle" >29 (8.1)</td><td align="center" valign="middle" >65 (18.1)</td><td align="center" valign="middle" >208 (57.9)</td><td align="center" valign="middle"  colspan="2"  >57 (15.9)</td><td align="center" valign="middle"  rowspan="2"  >&lt;0.001</td></tr><tr><td align="center" valign="middle" >Nonsmoker (n = 207)</td><td align="center" valign="middle" >67 (32.4)</td><td align="center" valign="middle" >85 (41.1)</td><td align="center" valign="middle" >51 (24.6)</td><td align="center" valign="middle"  colspan="2"  >4 (1.9)</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><p><sup>a</sup>Data are presented as number of patients (percentage of patients); <sup>b</sup>Pearson Chi-square test for association.</p><table-wrap id="table6" ><label><xref ref-type="table" rid="table6">Table 6</xref></label><caption><title> Logistic regression analysis for demographic and lipid variables vs. Freisinger index<sup>a</sup></title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Variable</th><th align="center" valign="middle" >Regression coefficient</th><th align="center" valign="middle" >Odds ratio</th><th align="center" valign="middle" >95% confidence interval</th><th align="center" valign="middle" >P value for regression</th></tr></thead><tr><td align="center" valign="middle"  colspan="5"  >Demographic variables</td></tr><tr><td align="center" valign="middle" >Age</td><td align="center" valign="middle" >0.004</td><td align="center" valign="middle" >1.004</td><td align="center" valign="middle" >0.982 - 1.026</td><td align="center" valign="middle" >0.729</td></tr><tr><td align="center" valign="middle" >Male gender</td><td align="center" valign="middle" >0.008</td><td align="center" valign="middle" >1.008</td><td align="center" valign="middle" >0.603 - 1.682</td><td align="center" valign="middle" >0.977</td></tr><tr><td align="center" valign="middle" >BMI</td><td align="center" valign="middle" >0.101</td><td align="center" valign="middle" >1.106</td><td align="center" valign="middle" >1.009 - 1.212</td><td align="center" valign="middle" >0.032</td></tr><tr><td align="center" valign="middle" >Diabetes mellitus</td><td align="center" valign="middle" >2.043</td><td align="center" valign="middle" >7.710</td><td align="center" valign="middle" >4.598 - 12.929</td><td align="center" valign="middle" >&lt;0.001</td></tr><tr><td align="center" valign="middle" >Hypertension</td><td align="center" valign="middle" >1.312</td><td align="center" valign="middle" >3.713</td><td align="center" valign="middle" >2.342 - 5.886</td><td align="center" valign="middle" >&lt;0.001</td></tr><tr><td align="center" valign="middle" >Smoking</td><td align="center" valign="middle" >1.755</td><td align="center" valign="middle" >5.784</td><td align="center" valign="middle" >3.637 - 9.197</td><td align="center" valign="middle" >&lt;0.001</td></tr><tr><td align="center" valign="middle"  colspan="5"  >Lipid variables</td></tr><tr><td align="center" valign="middle" >Total cholesterol</td><td align="center" valign="middle" >0.004</td><td align="center" valign="middle" >1.004</td><td align="center" valign="middle" >0.982 - 1.026</td><td align="center" valign="middle" >0.727</td></tr><tr><td align="center" valign="middle" >HDL cholesterol</td><td align="center" valign="middle" >−0.022</td><td align="center" valign="middle" >0.978</td><td align="center" valign="middle" >0.918 - 1.042</td><td align="center" valign="middle" >0.497</td></tr><tr><td align="center" valign="middle" >Triglycerides</td><td align="center" valign="middle" >0.000</td><td align="center" valign="middle" >1.000</td><td align="center" valign="middle" >0.990 - 1.010</td><td align="center" valign="middle" >0.983</td></tr><tr><td align="center" valign="middle" >Triglycerides/HDL cholesterol</td><td align="center" valign="middle" >0.014</td><td align="center" valign="middle" >1.014</td><td align="center" valign="middle" >0.984 - 1.046</td><td align="center" valign="middle" >0.360</td></tr><tr><td align="center" valign="middle" >Triglycerides/non-HDL cholesterol</td><td align="center" valign="middle" >0.153</td><td align="center" valign="middle" >1.165</td><td align="center" valign="middle" >0.374 - 3.626</td><td align="center" valign="middle" >0.792</td></tr></tbody></table></table-wrap><p><sup>a</sup>Binary logistic regression analysis.</p><p>rapid progression of coronary artery disease and increased risk of formation of new coronary artery lesions [<xref ref-type="bibr" rid="scirp.58617-ref14">14</xref>] -[<xref ref-type="bibr" rid="scirp.58617-ref16">16</xref>] . Further, the ratio of triglycerides to HDL cholesterol has shown promising findings as an attractive surrogate index of the atherogenicity of the plasma lipid profile [<xref ref-type="bibr" rid="scirp.58617-ref17">17</xref>] . Although such associations between lipid profile and obstructive coronary artery disease are well known [<xref ref-type="bibr" rid="scirp.58617-ref18">18</xref>] , few data exist regarding the association between lipid levels and extent or severity of coronary lesions in patients with coronary artery disease.</p><p>In our study, total cholesterol, triglycerides, LDL cholesterol, VLDL cholesterol, and non-HDL cholesterol showed an increasing trend with an increase in FR index. On the other hand, HDL cholesterol levels showed decreasing trend with an increase in the FR index. Corresponding lipid ratios of triglycerides/HDL cholesterol and triglycerides/non-HDL cholesterol were increasing with an increase in FR index. Overall, these findings were in agreement with other study of similar nature [<xref ref-type="bibr" rid="scirp.58617-ref8">8</xref>] . These findings validate the high risk profile for obstructive coronary artery disease in patients with abnormal lipid levels, which makes this population appropriate for the analysis of the correlation between lipid profile and extent of impairment of the coronary arteries.</p><p>Earlier, Da Luz et al. [<xref ref-type="bibr" rid="scirp.58617-ref8">8</xref>] investigated the association among lipid levels, specifically triglycerides/HDL cholesterol, and the extent of coronary disease in 374 high-risk patients who underwent coronary angiography. They found that the relationship between the extent of coronary disease (dichotomized by a FR index of 5) and lipid levels (normal vs. abnormal) was statistically significant for triglycerides, HDL cholesterol, and triglycerides/HDL cholesterol. However, the relationship was not significant between extent of coronary disease and total cholesterol or LDL cholesterol [<xref ref-type="bibr" rid="scirp.58617-ref8">8</xref>] . In contrary to this study, we had divided the patients in the present study in to four groups based on FR index scores of 0, 1 - 4, 5 - 10, and 11 - 15 respectively. We observed that HDL cholesterol levels, triglycerides levels, and triglycerides/non-HDL cholesterol ratio had a significant association with severity of FR index in our patients. However, it should be noted that logistic regression analysis indicated an insignificant link between FR index and lipid variables.</p><p>Overall, we suggest that emphasis should be given on diagnosis and management of dyslipidemia, which is a major modifiable risk factor for the development of coronary artery disease. We are of opinion that identification and control of potential lipid variables are very crucial in the primary and secondary prevention of coronary artery disease and subsequent cardiovascular events. It is also noteworthy that other modifiable risk factors such as BMI, hypertension, diabetes, and smoking are proved to be associated with extent of coronary artery disease in our study. Of significance, the role of hypertension, diabetes, smoking, and obesity was much stronger than the role of lipid variables in predicting the FR index, as demonstrated by logistic regression analysis in the current study.</p><p>Our study has several limitations. We compared only lipid variables, and did not take the current use of medication into account. The use of angiotensin enzyme inhibitors or angiotensin II receptor blockers may weaken the relationship between lipid variables and the FR index, effect of which remains unknown in our study. In addition, the patients enrolled in our study present with clinically indicated angiography for diagnostic purposes; hence, it remains unknown whether our findings extend to general population without a history of cardiovascular events. In conclusion, the present study indicates that lipid levels, particularly HDL cholesterol, triglycerides, and triglycerides/non-HDL are useful indicators of development of coronary heart disease, and are significantly associated with the FR index score indicating the extent and severity of coronary artery lesions. Other factors such as hypertension, diabetes, smoking, and obesity also play a significant role. Further studies with large sample size may establish lipid variables as easy and non-invasive tools of predicting the presence and extent of coronary atherosclerosis.</p></sec><sec id="s5"><title>Cite this paper</title><p>DeepeshAgarwal,Ramanand P.Sinha,Ram MohanJaiswal,NikhilPursnani,NirlepGajiwala,AshokThakkar, (2015) Link between Friesinger Index and Lipid Profile in Patients Undergoing Diagnostic Coronary Angiography. International Journal of Clinical Medicine,06,538-546. doi: 10.4236/ijcm.2015.68072</p></sec></body><back><ref-list><title>References</title><ref id="scirp.58617-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Penalva, R.A., Huoya Mde, O., Correia, L.C., Feitosa, G.S. and Ladeia, A.M. (2008) Lipid Profile and Intensity of Atherosclerosis Disease in Acute Coronary Syndrome. Arquivos Brasileiros de Cardiologia, 90, 24-30.</mixed-citation></ref><ref id="scirp.58617-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Smith, S.C., Jackson, R., Pearson, T.A., Fuster, V., Yusuf, S., Faergeman, O., et al. (2004) Principles for National and Regional Guidelines on Cardiovascular Disease Prevention: A Scientific Statement from the World Heart and Stroke Forum. Circulation, 109, 3112-3121. http://dx.doi.org/10.1161/01.CIR.0000133427.35111.67</mixed-citation></ref><ref id="scirp.58617-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Shen, Z., Munker, S., Wang, C., Xu, L., Ye, H., Chen, H., et al. (2014) Association between Alcohol Intake, Overweight, and Serum Lipid Levels and the Risk Analysis Associated with the Development of Dyslipidemia. Journal of Clinical Lipidology, 8, 273-278. http://dx.doi.org/10.1016/j.jacl.2014.02.003</mixed-citation></ref><ref id="scirp.58617-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Watts, G.F., Mandalia, S., Brunt, J.N.H., Slavin, B.M., Coltart, D.J. and Lewis, B. (1993) Independent Associations between Plasma Lipoprotein Subfraction Levels and the Course of Coronary Artery Disease in the St. Thomas’ Atherosclerosis Regression Study (STARS). Metabolism, 42, 1461-1467. http://dx.doi.org/10.1016/0026-0495(93)90199-X</mixed-citation></ref><ref id="scirp.58617-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Korhonen, T., Savolainen, M.J., Koistinen, M.J., Ik&amp;aumlheimo, M., Linnaluoto, M.K., Kervinen, K., et al. (1996) Association of Lipoprotein Cholesterol and Triglycerides with the Severity of Coronary Artery Disease in Men and women. Atherosclerosis, 127, 213-220. http://dx.doi.org/10.1016/S0021-9150(96)05958-8</mixed-citation></ref><ref id="scirp.58617-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Saku, K., Zhang, B., Ohta, T. and Arakawa, K. (1999) Quantity and Function of High Density Lipoprotein as an Indicator of Coronary Atherosclerosis. Journal of the American College of Cardiology, 33, 436-443.http://dx.doi.org/10.1016/S0735-1097(98)00560-9</mixed-citation></ref><ref id="scirp.58617-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Prajapati, J. Joshi, H., Sahoo, S., Virparya, K., Parmar, M. and Shah, K. (2015) AGE-Related Differences of Novel Atherosclerotic Risk Factors and Angiographic Profile Among Gujarati Acute Coronary Syndrome Patients. Journal of Clinical and Diagnostic Research, 9, OC05-OC09. http://dx.doi.org/10.7860/jcdr/2015/11709.6000</mixed-citation></ref><ref id="scirp.58617-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">da Luz, P.L., Favarato, D., Faria-Neto, J.R. Jr., Lemos, P. and Chages, A.C. (2008) High Ratio of Triglycerides to HDL-Cholesterol Predicts Extensive Coronary Disease. Clinics (Sao Paulo), 63, 427-432.http://dx.doi.org/10.1590/S1807-59322008000400003</mixed-citation></ref><ref id="scirp.58617-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Rinqqvist, I., Fisher, L.D., Mock, M., Davis, K.B., Wedel, H., Chaitman, B.R., et al. (1983) The Coronary Artery Surgery Study. Prognostic Value of Angiographic Indices of Coronary Artery Disease from the Coronary Artery Surgery Study (CASS). Journal of Clinical Investigation, 71, 1854-1866. http://dx.doi.org/10.1172/JCI110941</mixed-citation></ref><ref id="scirp.58617-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Rudel, L.L. and Kesainiemi, A. (2000) Low-Density Lipoprotein Particle Composition: What Is the Contribution to Atherogenicity? Current Opinion in Lipidology, 11, 227-228. http://dx.doi.org/10.1097/00041433-200006000-00001</mixed-citation></ref><ref id="scirp.58617-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Lada, A.T. and Rudel, L.L. (2004) Associations of Low Density Lipoprotein Particle Composition with Atherogenicity. Current Opinion in Lipidology, 15, 19-24. http://dx.doi.org/10.1097/00041433-200402000-00005</mixed-citation></ref><ref id="scirp.58617-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Miller, G.L. and Miller, N.E. (1975) Plasma High-Density Lipoprotein Concentration and the Development of Ischaemic Heart Disease. The Lancet, 1, 16-19. http://dx.doi.org/10.1016/S0140-6736(75)92376-4</mixed-citation></ref><ref id="scirp.58617-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Izuhara, M., Ono, K., Shiomi, H., Morimoto, T., Furukawa, Y., Nakagawa, Y., et al. (2015) High-Density Lipoprotein Cholesterol Levels and Cardiovascular Outcomes in Japanese Patients after Percutaneous Coronary Intervention: A Report from the CREDO-Kyoto Registry Cohort-2. Atherosclerosis, In Press.http://dx.doi.org/10.1016/j.atherosclerosis.2015.05.010</mixed-citation></ref><ref id="scirp.58617-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Assmann, G. and Schulte, H. (1992) Role of Triglycerides in Coronary Artery Disease: Lessons from the Prospective Cardiovascular Munster Study. American Journal of Cardiology, 70, 10H-13H.</mixed-citation></ref><ref id="scirp.58617-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Cullen, P. (2000) Evidence that Triglycerides Are an Independent Coronary Heart Disease Risk Factor. American Journal of Cardiology, 86, 943-949. http://dx.doi.org/10.1016/S0002-9149(00)01127-9</mixed-citation></ref><ref id="scirp.58617-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Hokanson, J.E. and Austin, M.A. (1996) Plasma Triglyceride Level Is a Risk Factor for Cardiovascular Disease Independent of High-Density Lipoprotein Cholesterol Level: A Meta-Analysis of Population Based Prospective Studies. Journal of Cardiovascular Risk, 3, 213-219. http://dx.doi.org/10.1097/00043798-199604000-00014</mixed-citation></ref><ref id="scirp.58617-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Hong, M.K., Romm, P.A., Reagan, K., Green, C.E. and Rackley, C.E. (1991) Usefulness of the Total Cholesterol to High Density Lipoprotein Cholesterol Ratio in Predicting Angiographic Coronary Disease in Women. American Journal of Cardiology, 68, 1646-1650. http://dx.doi.org/10.1016/0002-9149(91)90323-D</mixed-citation></ref><ref id="scirp.58617-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Bampi, A.B., Rochitte, C.E., Favaqrato, D., Lemos, P.A. and Da Luz, P.L. (2009) Comparison of Non-Invasive Methods for the Detection of Coronary Atherosclerosis. Clinics Sao Paulo, 64, 675-682.http://dx.doi.org/10.1590/S1807-59322009000700012</mixed-citation></ref></ref-list></back></article>